Patents by Inventor Risa NODERA

Risa NODERA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crosslinked chondroitin sulfate, composition containing same, and treatment agent for eye disease
    Patent number: 11207345
    Abstract: Provided is a chondroitin sulfate derivative having a cross-linked structure through a group in a polyvalent amine. Also provided is a composition containing the chondroitin sulfate derivative. Also provided are an agent and method for the treatment of an eye disease, the agent and method having a therapeutic effect on a corneal epithelial disorder and/or dry eye.
    Type: Grant
    Filed: June 9, 2020
    Date of Patent: December 28, 2021
    Assignee: SEIKAGAKU CORPORATION
    Inventors: Sho Funayama, Risa Nodera, Takahiro Hatanaka
  • CROSSLINKED CHONDROITIN SULFATE, COMPOSITION CONTAINING SAME, AND TREATMENT AGENT FOR EYE DISEASE
    Publication number: 20210052634
    Abstract: Provided is a chondroitin sulfate derivative having a cross-linked structure through a group in a polyvalent amine. Also provided is a composition containing the chondroitin sulfate derivative. Also provided are an agent and method for the treatment of an eye disease, the agent and method having a therapeutic effect on a corneal epithelial disorder and/or dry eye.
    Type: Application
    Filed: June 9, 2020
    Publication date: February 25, 2021
    Applicant: SEIKAGAKU CORPORATION
    Inventors: Sho FUNAYAMA, Risa NODERA, Takahiro HATANAKA
  • CROSSLINKED CHONDROITIN SULFATE, COMPOSITION CONTAINING SAME, AND TREATMENT AGENT FOR EYE DISEASE
    Publication number: 20190365796
    Abstract: Provided is a chondroitin sulfate derivative having a cross-linked structure through a group in a polyvalent amine. Also provided is a composition containing the chondroitin sulfate derivative. Also provided are an agent and method for the treatment of an eye disease, the agent and method having a therapeutic effect on a corneal epithelial disorder and/or dry eye.
    Type: Application
    Filed: August 9, 2019
    Publication date: December 5, 2019
    Applicant: SEIKAGAKU CORPORATION
    Inventors: Sho FUNAYAMA, Risa NODERA, Takahiro HATANAKA
  • Crosslinked chondroitin sulfate, composition containing same, and treatment agent for eye disease
    Patent number: 10420796
    Abstract: Provided is a chondroitin sulfate derivative having a cross-linked structure through a group in a polyvalent amine. Also provided is a composition containing the chondroitin sulfate derivative. Also provided are an agent and method for the treatment of an eye disease, the agent and method having a therapeutic effect on a corneal epithelial disorder and/or dry eye.
    Type: Grant
    Filed: January 15, 2016
    Date of Patent: September 24, 2019
    Assignee: SEIKAGAKU CORPORATION
    Inventors: Sho Funayama, Risa Nodera, Takahiro Hatanaka
  • CROSSLINKED CHONDROITIN SULFATE, COMPOSITION CONTAINING SAME, AND TREATMENT AGENT FOR EYE DISEASE
    Publication number: 20170368093
    Abstract: Provided is a chondroitin sulfate derivative having a structure cross-linked with a group in a polyvalent amine. Also provided is a composition containing the chondroitin sulfate derivative. Also provided are an agent and method for the treatment of an eye disease, the agent and method having a therapeutic effect on a corneal epithelial disorder and/or dry eye.
    Type: Application
    Filed: January 15, 2016
    Publication date: December 28, 2017
    Applicant: SEIKAGAKU CORPORATION
    Inventors: Sho FUNAYAMA, Risa NODERA, Takahiro HATANAKA